Our findings showed that there were significant differences between the survival and death groups of Amanita poisoning patients in terms of the clinical features (gastrointestinal bleeding, dizziness and headache, delirious coma, infection, and shortness of breath) and the biochemical indicators (ALT, AST, PT and APTT), suggesting that the death patients with Amanita poisoning had more serious liver and coagulation function damage, which were consistent with numerous previous research findings (Trabulus and Altiparmak, 2011; Le Daré et al., 2021). The gene discussed is GPT; the disease is infection.